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Abstract
Background: Antibiotic resistance is a global health threat. Public knowledge is considered a prerequisite for
appropriate use of antibiotics and limited spread of antibiotic resistance. Our aim was to examine the level of
knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy customers, and to assess to which
degree beliefs, attitudes and sociodemographic factors are associated with this knowledge.
Methods: A questionnaire based, cross-sectional study was conducted among pharmacy customers in three
Norwegian cities. The questionnaire covered 1) knowledge of antibiotics (13 statements) and antibiotic resistance (10
statements), 2) the general beliefs about medicines questionnaire (BMQ general) (three subdomains, four statements
each), 3) attitudes toward antibiotic use (four statements), and 4) sociodemographic factors, life style and health. High
knowledge level was defined as > 66% of maximum score. Factors associated with knowledge of antibiotics and
antibiotic resistance were investigated through univariate and multiple linear regression. Hierarchical model regression
was used to estimate a population average knowledge score weighted for age, gender and level of education.
Results: Among 877 participants, 57% had high knowledge of antibiotics in general and 71% had high knowledge of
antibiotic resistance. More than 90% knew that bacteria can become resistant against antibiotics and that unnecessary
use of antibiotics can make them less effective. Simultaneously, more than 30% erroneously stated that antibiotics are
effective against viruses, colds or influenza. Factors positively associated with antibiotic knowledge were health
professional background, high education level, and a positive view on the value of medications in general. Male
gender, a less restrictive attitude toward antibiotic use, and young age were negatively associated with antibiotic
knowledge. The mean overall antibiotic knowledge score was relatively high (15.6 out of maximum 23 with estimated
weighted population score at 14.8).
Conclusions: Despite a high level of knowledge of antibiotics and antibiotic resistance among Norwegian pharmacy
customers, there are obvious knowledge gaps. We suggest that action is taken to increase the knowledge level, and
particularly target people in vocational, male dominated occupations outside the health service, and primary/
secondary school curricula.
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Background
According to the World Health Organization (WHO),
“Antibiotic resistance is one of the biggest threats to glo-
bal health, food security, and development today” [1]. In-
creased use of antibiotics worldwide, both in human
medicine and in agriculture, has led to increased occur-
rence of resistant bacteria [2]. Parallel to the spread of
bacterial resistance, there has been a decline in research
and development of new antibiotics [3].
Inappropriate prescribing and/or overuse of antibiotics
among patients are regarded among the main causes of
the emergence of resistant bacteria [3]. Although
Norway has relatively low use of antibiotics (18 DDD/
1000 inhabitants/day in 2016) and can show a reduction
in overall consumption in later years [4, 5], there are
some causes for concern. The proportion of
broad-spectrum antibiotic use has increased [5]. Also,
we have seen an increased number of carriers, but also
infections, of Methicillin-resistant Staphylococcus aureus
(MRSA) since 2010, in addition to several major out-
breaks of Vancomycin-resistant enterococci (VRE) [6].
The Norwegian national strategy against antibiotic re-
sistance (2015–2020) aims to reduce antibiotic use (mea-
sured in DDD/1000 inhabitants/day) by 30% from 2012
to 2020 [7], i.e. from 21 to 15 DDD/1000 inhabitants/
day [5]. One of the means to achieve this aim has been
to shorten the period of validity for antibiotic prescrip-
tions from one year to ten days, effective from January
2018. Other actions include information campaigns to-
ward both health professions and the general
population.
The European strategy describes guidelines for the
member states [8]. It does not specify a definite aim for
reduced use of antibiotics, but states that the EU will
monitor the progress through key outcome indicators.
Several actions are planned, e.g. to support national
awareness-raising efforts through “communication tools
targeting key audiences and contribute to the annual
European Antibiotic Awareness Day (EAAD)” [8].
Independent information and public education about
medicines are two of the 12 key interventions that
WHO advocates to promote more rational medicine use
in general [9]. When it comes to antibiotics, the first
strategic objective of the WHO Global action plan on
antimicrobial resistance is to improve public awareness
and understanding of the problem [10]. The Norwegian
and European strategies likewise emphasizes increased
public knowledge [7, 8]. A European survey (excl.
Norway), the 2016 Eurobarometer, shows great variabil-
ity between countries regarding public knowledge of an-
tibiotics [11].
Information campaigns have been launched in several
countries, with varying effects on antibiotic use [12]. As
a part of the national strategy to increase public
knowledge, the Norwegian Ministry of Health and Care
Services launched a public information campaign, con-
ducted by the Norwegian Directorate of Health in 2016,
about the consequences of antibiotic resistance [13]. The
campaign were primarily aimed at social media (Face-
book) and included two short videos as well as magazine
advertisements and boards produced by a communica-
tion agency. The target population was mothers with
children aged < 6 years and adults 25–44 years although
the posts were open for all [14]. By October 2018, the




Independently of official information strategies, media
may have covered various aspects of the antibiotic resist-
ance challenge [15, 16]. In Norway, in addition to nu-
merous newspaper articles, a reputable documentary
series on the main national broadcasting channel ad-
dressed antibiotic resistance in March 2016 [17]. Social
media have become important information channels, but
may not reach people with low knowledge and/or low
interest in the subject [18, 19].
Awareness about antibiotic resistance has been shown
to be lower in countries where antibiotic resistance is
high [20]. Within the EU, countries with low use of anti-
biotics, such as Sweden and The Netherlands, show a
higher population knowledge level [11]. Consequently,
the hypothesis is that increased knowledge of antibiotics
among the general population can help achieve appro-
priate use, better treatment adherence and results, and
consequently reduce bacterial resistance. People’s atti-
tudes, beliefs and views regarding medicines may influ-
ence their knowledge of antibiotics and antibiotic
resistance [20–23]. So far, this has not been investigated
in a Norwegian population.
Aim
The primary aim was to examine the level of knowledge
of antibiotics and antibiotic resistance in the Norwegian
population, explored among pharmacy customers. The
secondary aim was to assess to which degree beliefs, atti-
tudes and sociodemographic factors are associated with
this knowledge.
Material and methods
We carried out a questionnaire based, cross-sectional
study among pharmacy customers from 20 pharmacies
in three Norwegian cities representing different parts of
the country: Tromsø in the north (~ 80,000 inhabitants),
Bergen in the southwest (~ 272,000 inhabitants) and
Skien in the southeast (~ 55,000 inhabitants)). These cit-
ies were selected based on the location of the collaborat-
ing university departments represented in the project
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team, as well as their proximity to the area of residency
of the master students performing the data collection.
The pharmacies were chosen either based on their large
client base (six in Bergen and two in Skien), or all phar-
macies in the municipality were chosen (Tromsø, 12
pharmacies). Four pharmacy students (in their final (5th)
year) from the Universities of Tromsø, Bergen and Oslo
collaborated on the data collection, which took place
from October 2016 to February 2017. The inclusion cri-
teria were ≥ 18 years of age and ability to understand
Norwegian. The master students were present in the
pharmacy at all times during data collection to facilitate
questionnaire completion, e.g. show them to the phar-
macy information room or provide postage paid enve-
lopes if they were in a hurry, and to prevent
misunderstandings if they had difficulties understanding
some of the questions. All individuals who entered the
pharmacy during the appointed time for data collection
were invited to participate.
A structured questionnaire in Norwegian was devel-
oped by the project team consisting of researchers with
extensive experience in conducting questionnaire-based
studies as well as clinical experience and expertise in
pharmacy practice. The master students conducted a
face validity study for assessment of comprehensibility
and completion time among persons without health pro-
fessional background (N = 29). Based on the results from
this study, the questionnaire was shortened and some of
the questions were rephrased. The revised version, tested
among an additional six persons in Tromsø, showed that
mean completion time at this study site was reduced
from 41min for the original questionnaire, to 26 min for
the revised version. Participants from the face validity
study were excluded from the main study. The complete
questionnaire was not validated, but included some vali-
dated questions, i.e. the Beliefs about Medicines Ques-
tionnaire (BMQ) [24]. An English translation of the
questionnaire is available upon request.
Measures
The questionnaire was organised in four parts: 1) know-
ledge of antibiotics and antibiotic resistance, 2) general be-
liefs about medicines, 3) attitudes toward antibiotic use
and 4) sociodemographic factors, lifestyle and health.
Knowledge of antibiotics and antibiotic resistance
The antibiotic knowledge part consisted of 23 state-
ments, 13 regarding antibiotics in general and 10 regard-
ing antibiotic resistance. Six items were sampled from
the Eurobarometer [11], and the remaining items were
based on experience from clinical or pharmacy settings.
Response alternatives were “True”, “False” and “Do not
know”. Results are presented as percentage correct an-
swers per statement. For each statement, knowledge was
considered satisfactory if ≥80% of the participants an-
swered correctly. Additionally, an overall knowledge
score across items was calculated by giving each item
one point for correct answer, while wrong answer, “do
not know” and missing were set to zero. The overall
maximum score was 23, i.e. 13 for antibiotics in general
and 10 for antibiotic resistance. High knowledge level
was defined as a mean score > 66% of maximum score
(the double of what would be achievable on average by
random answering), i.e. > 8.66 for antibiotics in general
and > 6.66 for antibiotic resistance.
General beliefs about medicines
Beliefs about medicines were measured by the beliefs about
medicines questionnaire (BMQ general) [24]. The instru-
ment consists of three domains: BMQ overuse, BMQ harm
and BMQ benefit, each containing four items (belief state-
ments) measured by a 5-point Likert scale; strongly dis-
agree (1), disagree (2), uncertain (3), agree (4) and strongly
agree (5). Each domain gives a score from 4 to 20. The Nor-
wegian language version of BMQ overuse and harm has
been validated [25], but not BMQ benefit. In addition to
total score sum, the mean score per domain was calculated
as overall score divided by the number of items per domain,
making it comparable to the Likert scale.
Attitudes toward antibiotic use
To measure attitudes toward antibiotics, we used four
statements from a web survey commissioned by the Nor-
wegian Directorate of Health [26]: “I only wish to use anti-
biotics if it is necessary”, “The doctor should not give me
antibiotics when he/she thinks I do not need it”, “I wish to
use antibiotics if I get well sooner”, and “The doctor should
give me antibiotics when I think I need it”. We used the
same 5-point Likert scale as described above. As a restrict-
ive attitude is preferred when it comes to antibiotic use, we
combined the first two statement into a total score (2–10)
for restrictive attitude toward antibiotics (i.e. “only if neces-
sary” and “not if I do not need it”). Similarly, the last two
statements were combined into a total score for less re-
strictive attitude (i.e. “if I get well sooner” and “when I think
I need it”). As for the BMQ, the mean score per domain
was calculated as overall score divided by the number of
items per domain, making it comparable to the Likert scale.
Sociodemographic factors, life style and health
We included questions on age, gender, work situation,
level of education, health professional background, mari-
tal status, health status, chronic disease, regular medica-
tion use, antibiotic use in the previous 12months and
smoking. Variables were categorized as presented in
Table 1. Work situation was categorized as in active
work, not working (but of working age, i.e. unemployed,
housewife etc.), student and retired. The education
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Table 1 Participants characteristics and proportion with high antibiotic knowledge scorea
n (%) High antibiotics knowledge scoreb
Antibiotics in general Antibiotic resistance
n (%) n (%)
Age
18–29 years 178 (20.3) 91 (51.1) 104 (58.4)
30–44 years 166 (18.9) 111 (66.9) 123 (74.1)
45–59 years 215 (24.5) 135 (62.8) 163 (75.8)
> =60 years 316 (36.0) 164 (51.9) 233 (73.7)
Gender
Women 598 (68.2) 384 (64.2) 428 (71.5)
Men 277 (31.6) 117 (42.2) 195 (70.4)
Health statement I have good health
Strongly agree 240 (27.4) 140 (58.3) 175 (72.9)
Agree 418 (47.7) 244 (58.4) 306 (73.2)
Unsure 102 (11.6) 51 (50.0) 66 (64.7)
Disagree 94 (10.7) 56 (59.6) 64 (68.1)
Strongly disagree 18 (2.1) 9 (50.0) 9 (50.0)
Chronic disease
Yes 381 (43.4) 256 (67.2) 275 (72.2)
No 470 (53.6) 233 (49.6) 333 (70.9)
Will not report 18 (2.1) 9 (50.0) 10 (55.6)
Smoking
Yes 90 (10.3) 49 (54.4) 57 (63.3)
No 732 (83.8) 424 (57.9) 535 (73.1)
Sometimes 52 (5.9) 28 (53.8) 31 (59.6)
Regular medication use
Yes 498 (57.0) 280 (56.2) 355 (71.3)
No 314 (35.9) 186 (59.2) 228 (72.6)
Sometimes 62 (7.1) 34 (54.8) 38 (61.3)
Antibiotics use last 12 months
Yes 262 (29.9) 164 (62.6) 184 (70.2)
No 602 (68.6) 332 (55.2) 432 (71.8)
Do not remember 12 (1.4) 5 (41.7) 7 (58.3)
Education
Primary/lower secondary school 69 (7.9) 29 (42.0) 38 (55.1)
Upper secondary school 307 (35.0) 162 (52.8) 190 (61.9)
College/University ≤3 years 242 (27.6) 133 (55.0) 185 (76.4)
College/University > 3 years 247 (28.2) 171 (69.2) 205 (83.0)
Health professional background
Yes 233 (26.6) 189 (81.1) 196 (84.1)
No 609 (69.4) 291 (47.8) 407 (66.8)
Do not know 17 (1.9)) 12 (70.6) 8 (47.1)
Marital status
Married/cohabiting 546 (62.3) 331 (60.6) 410 (75.1)
In a relationship 71 (8.1) 33 (46.5) 44 (61.9)
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categories were primary/lower secondary school, upper
secondary school, college/university ≤3 years and col-
lege/university > 3 years. We merged the college/univer-
sity categories when calculating a weighted knowledge
score for the general population, because Statistics
Norway splits higher education at ≤4 years/> 4 years.
Chronic disease was defined as disease that progresses
slowly, is long-lasting or recurrent.
Statistical analyses
We used R version 3.4.1, R Foundation for Statistical
Computing, Vienna, Austria (https://www.R-project.org/
) for the statistical analyses. We present descriptive sta-
tistics as means with standard deviations (SD) or fre-
quencies with proportions (%). Factors associated with
knowledge of antibiotics and antibiotic resistance
were investigated through univariate and multiple lin-
ear regression. Inspection of diagnostic plots of resid-
uals (normal QQ, Residuals vs Fitted, Scale-Location
and Residuals vs Leverage) did not reveal serious vio-
lation of test assumptions. We performed hierarchical
model regression to estimate an average knowledge
score for the general population, weighted for age,
gender and education.
Table 1 Participants characteristics and proportion with high antibiotic knowledge scorea (Continued)
n (%) High antibiotics knowledge scoreb
Antibiotics in general Antibiotic resistance
n (%) n (%)
Single 232 (26.5) 123 (53.0) 152 (65.5)
Other 23 (2.6) 12 (52.2) 14 (60.9)
Work situation
In active work 292 (33.3) 190 (65.1) 231 (79.1)
Not working 226 (25.8) 140 (61.9) 148 (65.5)
Student 90 (10.3) 47 (52.2) 54 (60.0)
Retired 249 (28.4) 113 (45.4) 178 (71.5)
Beliefs about medicinesc
Beneficial
Agree 818 (93.3) 472 (57.7) 593 (72.5)
Uncertain 32 (3.6) 12 (37.5) 13 (40.6)
Disagree 27 (3.1) 17 (63.0) 18 (66.7)
Harmful
Agree 169 (19.3) 82 (48.5) 109 (64.5)
Uncertain 112 (12.8) 65 (58.0) 71 (63.4)
Disagree 596 (68.0) 354 (59.4) 444 (74.5)
Overused
Agree 465 (53.0) 274 (58.9) 336 (72.3)
Uncertain 154 (17.6) 81 (52.6) 99 (64.3)
Disagree 258 (29.4) 146 (56.6) 189 (73.3)
Attitude toward antibioticsc
Restrictive attitude supported
Agree 836 (95.3) 483 (57.8) 600 (71.8)
Uncertain 35 (4.0) 16 (45.7) 20 (57.1)
Disagree 5 (0.6) 1 (20.0) 3 (60.0)
Non-restrictive attitude supported
Agree 215 (24.5) 107 (49.8) 147 (68.4)
Uncertain 185 (21.3) 99 (53.5) 119 (64.3)
Disagree 476 (54.3) 294 (61.8) 357 (75.0)
aProportion with mean score > 66% of maximum score (i.e. > 8.58 on general knowledge and > 6.66 on antibiotic resistance knowledge)
bTen participants had “do not know” on all 23 knowledge items while 59 had missing on at least one item. Number of missing per knowledge item varied from 0
to 11. All missing values were set to zero
cTotal score transposed to a 1–5 scale (mean of mean) and categorized as agree (4–5), uncertain (3) and disagree (1–2)
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Statistical significance was defined as p-values < 0.001
to adjust for multiple testing
For the BMQ and the attitude scores, participants with
missing on more than one item within a subdomain
were excluded from the analyses (n = 3). For other par-
ticipants, missing values were imputed by setting miss-
ing to 3 on the Likert scale (uncertain) (21 values were
imputed, 15 in BMQ and 6 in attitudes).
Results
The total study population comprised 877 participants
out of 2573 invited (overall response rate 34, 19% in Ber-
gen, 55% in Tromsø and 62% in Skien). Mean age was
49.6 (SD 18.4) years. One third of the participants were ≥
60 years and two thirds were women. Seventy-five per-
cent agreed that they had good health, 56% reported
higher education, 43% had a chronic disease, 57% used
medication regularly and 30% had used antibiotics dur-
ing the last 12 months.
Level of knowledge of antibiotics and antibiotic resistance
Overall, the proportion with high knowledge (> 66% of
maximum score) was 57% for antibiotics in general and
71% for antibiotic resistance. Fifty percent had high
knowledge level on both domains, while 21% had low
knowledge level on both domains.
Table 1 shows the participant characteristics and the cor-
responding proportion with high level of knowledge.
Among participants with a health professional background,
more than 80% had high knowledge score on both do-
mains, and people with the highest education showed simi-
lar results for antibiotic resistance. Groups with low
knowledge level included young people (< 60% with high
knowledge), the lowest education category (42 to 55%),
men (42% on antibiotics in general), and several relatively
small groups of people who expressed variations of uncer-
tainty (e.g. “uncertain” (Likert), “do not know”, “do not re-
member”, “sometimes”) (from 20% (n = 1), to around 60%).
Figure 1 shows the proportion of participants with ap-
propriate response to each of the 13 general and 10
Fig. 1 Proportion of participants with correct identification of true and false statements on antibiotics and antibiotic resistance
Waaseth et al. BMC Public Health           (2019) 19:66 Page 6 of 12
resistance specific statements on antibiotics. The know-
ledge level was generally high for most statements. Satis-
factory knowledge per statement (> 80% of the
participants gave correct answer) was achieved for two
out of 13 statements on antibiotics in general and for six
out of ten statements on antibiotic resistance. More than
90% knew that bacteria can become resistant against an-
tibiotics and that unnecessary use of antibiotics can
make them less effective. Items with particularly low
knowledge (< 50% of the participants gave appropriate
response) included “you can take antibiotics with all
kinds of food”, “penicillin is another word for antibiotic”,
“viruses can become resistant against antibiotics” and
“humans can become resistant against antibiotics”.
The mean overall antibiotic knowledge score was 15.6
(67.8% of maximum score), relatively higher on anti-
biotic resistance compared with general knowledge
(Table 2). The corresponding estimated average know-
ledge score for the general population was 14.8,
weighted for age, gender and education level.
General beliefs about medicines and attitudes toward
antibiotic use
The BMQ scores show that the study population had an
overall positive view of the value of medications with a
mean per subdomain score of 4.1 for benefit, 2.6 for
harm and 3.2 for overuse (Table 2). The study popula-
tion showed a restrictive attitude toward antibiotic use
with particularly high score on the restrictive items, and
low score on less restrictive items (Table 2).
Factors associated with antibiotic knowledge
Results from the multiple linear regression analysis
(Table 3) showed that participants with a health profes-
sional background were more likely to have higher
knowledge of antibiotics. Moreover, viewing medications
in general as beneficial (high score on BMQ benefit) was
associated with higher antibiotic knowledge. Knowledge
scores according to aggregated BMQ categories (Table
1) show that for five out of six comparisons, the middle
BMQ category (“uncertain”) had the lowest score, sug-
gesting that the associations may not be linear. A less re-
strictive attitude toward antibiotic use was negatively
associated with antibiotic knowledge, while a restrictive
attitude was suggestive of higher knowledge of antibiotic
resistance (borderline significance, p = 0.001).
Knowledge of antibiotics and antibiotic resistance dif-
fered according to some of the background characteris-
tics. Men were more likely to have lower general
knowledge of antibiotics than women, but there were no
gender difference in knowledge of antibiotic resistance.
Higher age and higher education was associated with
higher knowledge of antibiotic resistance but not of anti-
biotics in general. For education, this might have been a
question of statistical power, as the trend in the coeffi-
cients were similar for both scores. The knowledge
scores according to age category (Table 1) suggested an
inverse u-shaped rather than linear relationship between
age and general knowledge, with lower knowledge
among the youngest and oldest participants.
According to the univariate regression (see
Additional file 1), viewing medicines as harmful (high
score on BMQ harm) and not being in active work was
negatively associated with antibiotic knowledge, but this
was no longer statistically significant in the multivariable
analysis. The remaining sociodemographic factors
showed no significant impact on antibiotic knowledge.
Neither did any of the health related factors.
Discussion
This study among Norwegian pharmacy customers
shows a relatively high public knowledge of antibiotics
Table 2 Scores on antibiotic knowledge, general beliefs about medicines (BMQ) and attitude toward antibiotic use among
Norwegian pharmacy customers
Knowledge of antibiotics (score range) Mean score (SD) Percent of max score
AB general knowledge (1–13) 8.5 (2.8) 65.4%
AB resistance knowledge (1–10) 7.1 (2.1) 71.0%
Total AB knowledge (1–23) 15.6 (4.4) 67.8%
Beliefs about medicinesa (score range) Mean score (SD) Mean score/4b (SD)
BMQ benefit (4–20) 16.2 (2.4) 4.1 (0.6)
BMQ harm (4–20) 10.3 (2.7) 2.6 (0.7)
BMQ overuse (4–20) 12.7 (2.4) 3.2 (0.6)
Attitude toward antibiotic usea (score range) Mean score (SD) Mean score/2b (SD)
Restrictive attitude supported (2–10) 9.2 (1.1) 4.6 (0.6)
Non-restrictive attitude supported (2–10) 5.2 (1.9) 2.6 (1.0)
aFive-point Likert scale per statement (from strongly disagree = 1 to strongly agree = 5), 4 statements per BMQ domain, 2 statements per attitude domain
bDivided by the number of statements per domain, i.e. Likert scale 1–5 per domain
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Table 3 Association between various characteristics and knowledge of antibiotics and antibiotic resistance (multiple linear
regression)
Antibiotics, general knowledgec Antibiotic resistance knowledgec
Coeff. 95% CI Coeff. 95% CI
Beliefs about medicines, BMQ score
Benefit 0.116 0.037 0.195 0.132 0.074 0.190
Harm −0.062 −0.141 0.018 −0.034 − 0.092 0.024
Overuse 0.075 −0.005 0.156 0.020 −0.039 0.080
Attitude antibiotics, score
Restrictive 0.165 0.006 0.324 0.190 0.073 0.307
Less restrictive −0.161 −0.253 −0.069 − 0.190 −0.257 − 0.122
Agea
30–44 years 0.493 −0.147 1.133 0.923 0.452 1.394
45–59 years 0.719 0.092 1.345 1.092 0.631 1.553
> =60 years 0.497 −0.258 1.252 1.256 0.701 1.812
Gendera
Men − 0.867 − 1.253 −0.481 0.151 −0.134 0.435
Educationa
Upper secondary school 0.188 −0.504 0.880 0.211 −0.298 0.720
College/University ≤3y 0.219 −0.506 0.944 0.602 0.069 1.136
College/University >3y 0.808 0.063 1.553 0.977 0.429 1.525
Health professionalb
Yes 1.670 1.264 2.076 0.905 0.606 1.203
Do not know 1.412 0.156 2.668 −0.259 −1.183 0.664
Antibiotics use last 12 monthsb
Yes 0.333 −0.056 0.721 0.184 −0.101 0.470
Do not remember −1.026 −2.458 0.406 −1.451 −2.504 −0.397
Healthy
Score 0.081 −0.117 0.278 0.064 −0.082 0.209
Chronic diseaseb
Yes 0.550 0.112 0.988 0.009 −0.313 0.331
Will not tell −0.065 −1.307 1.177 −0.147 −1.061 0.767
Medicationb
Some times − 0.317 − 1.040 0.406 0.040 −0.492 0.572
Yes −0.746 −1.217 −0.274 − 0.310 −0.657 0.037
Smokingb
Some times − 0.077 − 0.806 0.653 −0.329 − 0.866 0.208
Yes 0.071 −0.517 0.659 −0.077 −0.510 0.355
Marital statusa
Relationship − 0.564 −1.274 0.146 0.251 −0.271 0.773
Single −0.176 −0.589 0.236 0.006 −0.297 0.310
Other −0.682 −1.779 0.414 −0.232 −1.038 0.575
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and antibiotic resistance comparable to studies from
Sweden [21, 22], and higher than in many other coun-
tries [23]. The higher knowledge scores on antibiotic re-
sistance compared with general knowledge of antibiotics
may be due to the increasing focus on antibiotic resist-
ance in media in later years [17]. This could also be seen
as a result of the national strategy against antibiotic re-
sistance [7], including the national information cam-
paign [13], which may have spurred the media focus.
Similarly to previous studies [21, 22, 27], we identified
that people tend to know that antibiotic resistance is a
result of inappropriate or unnecessary antibiotic use,
and that it makes the antibiotics less effective, but they
do not necessarily know what antibiotic resistance or
unnecessary use is. For instance, our data show that al-
most 90% believe that humans can become resistant
against antibiotics and many do not differentiate be-
tween bacteria and virus, with over 30% saying that anti-
biotics are effective against viruses, colds or influenza.
Some may not know that colds and influenza are all viral
infections. Considering the six knowledge statements in
common with the Eurobarometer [11], our study partici-
pants would have reached first place for knowing that
antibiotics do not kill viruses (76%), but only tenth for
correctly dismissing effectiveness against colds and influ-
enza. To mitigate unnecessary use of antibiotics, it
would be helpful if patients were aware of this. Our find-
ings are in accordance with an interview study commis-
sioned by the Norwegian Directorate of Health in 2016
(not published) [28]. Focus group interviews conducted
among Norwegian parents showed that there is an inter-
est in antibiotic resistance, but the concept is easily
misunderstood.
The particularly low score on penicillin being another
word for antibiotics is understandable as penicillin was
the first marketed antibiotic and a tremendously import-
ant medicinal discovery. It is also the most used
antibiotic in Norway and the name has become fixed in
people’s minds. Although this may seem trivial, it adds
unwanted confusion. For instance, patients may say they
are “allergic to penicillin”, and so the doctor unnecessar-
ily prescribes a broad-spectrum antibiotic. The state-
ment that antibiotics can be taken together with food
may be somewhat ambiguous, as many antibiotics are
not noticeably influenced by food intake, thereby leading
to uncertainty among the participants. Even for oral
penicillin, where food intake inhibits the absorption,
avoiding food is less important for optimal effect than
administering the doses at regular, frequent time inter-
vals [29].
Antibiotic knowledge was positively associated with
positive beliefs about medications and with increasingly
restrictive attitude toward antibiotic use. Our results are
in line with previous reports showing that beliefs and at-
titudes are important for knowledge of medications [30],
including antibiotics [20, 22, 31]. Interventions aiming
to increase knowledge of antibiotics may promote re-
strictive attitude toward antibiotics, thereby contributing
to reduced utilization and consequently lower selective
pressure and less antibiotic resistance. A similar influence
on beliefs about medications may contribute to stronger
adherence, and thereby optimized effect of the antibiotic
whenever a prescription is justified. This has been shown
in studies of selected patient groups [32, 33].
Being male, having low education and particularly not
having a health professional background was associated
with a lower level of knowledge of antibiotics. The gen-
der difference may reflect that women generally are
more concerned with health issues, for instance through
taking on a greater responsibility for children’s or par-
ents’ health [34], or specifically through experience with
antibiotic treatment. The prevalence of antibiotic use in
Norway is approximately 50% higher among women
than men [35], and the difference is largest among
Table 3 Association between various characteristics and knowledge of antibiotics and antibiotic resistance (multiple linear
regression) (Continued)
Antibiotics, general knowledgec Antibiotic resistance knowledgec
Coeff. 95% CI Coeff. 95% CI
Worka
Not working − 0.230 − 0.688 0.228 −0.469 − 0.805 −0.132
Student −0.113 −0.859 0.633 −0.065 − 0.614 0.484
Retired −0.831 −1.464 −0.198 − 0.450 −0.915 0.016
CI Confidence Interval, Coeff. beta coefficient from univariate linear regression
The numbers (coefficients and accompanying confidence Intervals (CI)) represent change in knowledge score for antibiotics in general and antibiotic
resistance respectively
Significant associations (p < 0.001) are marked in bold
aReference category is “18–29 years” for age, “women” for gender, “primary/lower secondary school” for education, “married/cohabiting” for marital status and
“active work” for work situation
bReference category is “no”
cTen participants had “do not know” on all 23 knowledge items while 59 had missing on at least one item. Number of missing per knowledge item varied from 0
to 11. All missing values were set to zero
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young adults [36]. Regarding our questionnaire, we
should also remember that awareness of vaginal yeast in-
fection probably is higher among women and may con-
tribute to the identified gender difference in general
knowledge. Age seems influential as younger people
show lower knowledge. This may indicate that the
knowledge of antibiotic resistance comes from higher
education or experience with antibiotic use, and is not
acquired in the basic compulsory educational system.
Also, healthy young people are probably less inclined to
show interest in disease related topics presented in trad-
itional media. Our results on gender and age influence
are in accordance with unpublished results from a web
survey commissioned by the Norwegian Directorate of
Health in 2016 [26]. Also noteworthy, is that the na-
tional campaign, which was ongoing during our data col-
lection period, was targeted toward mothers of small
children and adults 25–44 years [14].
As shown by a recent systematic review, the effect of
public information campaigns on antibiotic prescribing
tends to vary between different populations and study
designs [12]. A Norwegian study showed a reduced fre-
quency of bacterial infections presented at emergency
centres during autumn 2009 compared with previous
years, suggesting an impact of the public hygiene cam-
paign during the H1N1 influenza pandemic in 2009 [37].
According to our findings, a campaign to increase the
level of public knowledge of antibiotics in Norway would
probably be most effective if targeted toward people in
the less academic and particularly the male dominated
professions or occupations. Additionally, increased focus
on antibiotics at the primary and secondary school level
would increase the knowledge among the young genera-
tions and minimize knowledge gaps due to education
level when they grow older. At present, neither the core
curriculum for primary, secondary and adult education
in Norway nor the natural science subject curriculum
specify learning objectives regarding antibiotics [38]. A
general aim is “to enable pupils to explain how the body
protects itself against illness and how one can prevent
and treat infectious disease”, which leaves the degree of
depth on antibiotics to the teachers. A new national cur-
riculum will be developed during 2018 with implementa-
tion planned from 2019. This represents a timely
opportunity to increase the focus and knowledge of anti-
biotic resistance among future generations. The curriculum
should perhaps make room for “…one of the biggest threats
to global health, food security, and development” [1].
As the greatest knowledge gaps seems to be in general
antibiotic knowledge, a campaign should focus on this
area. Pharmacies are excellent arenas to spread correct
information on antibiotics. Particularly relevant issues
would be the three items with lowest rate of correct an-
swers within antibiotics in general: side effects of
antibiotics, combination with food and the concept of
antibiotics versus penicillin. However, as pharmacies
intercept not only people with antibiotic prescriptions
but also buyers of non-prescription cough and cold
products, there would be frequent opportunities to ex-
plain the difference between bacterial and viral infec-
tions, which would support the comprehension of
antibiotic resistance.
Given that the national campaign was effective, which
might have been the case as our findings show that
women and the middle age group have higher scores, we
think the Norwegian Directorate of Health should com-
mission a similar campaign targeted toward men in vo-
cational professions and fathers in general. This might
imply different means of action, for instance different
case examples and targeted messages in the campaign
material. A reasonable aim for a national campaign
would be to increase the public knowledge to above 80%
for all knowledge items in our study.
Strengths and limitations
To our knowledge, this is the first study of its kind in
Norway, thereby providing useful information on a
highly relevant topic. Although our study sample in
some respects deviates from the general population, the
highly significant associations with antibiotic knowledge
that we have identified from our material, would in all
likelihood also be significant in the general population.
The master students were present to answer questions
from the participants at all times during data collection.
This has contributed to the completeness of data, with
the maximum proportion of missing per question/state-
ment being 2.2% (work situation). Combined with im-
putation of missing values on BMQ and attitude score
variables, this ensured that only 6.9% of the population
were excluded in the multiple linear regression analysis.
The facilitation included help for participants who had
difficulties understanding some of the questions. This
implies a potential for overestimation of knowledge if
the students were too helpful, but also underestimation
if help had not been given. The students were conscious
not to influence the participants’ answering, so we as-
sume low influence from the facilitation.
The cross-sectional design prevents us from drawing
conclusions regarding causal relationships. For instance,
high knowledge of antibiotics may just as likely be a pre-
requisite for restrictive attitudes toward antibiotics as
vice versa.
The study population is not representative for the
Norwegian general population ≥ 18 years. Our sample is
somewhat older with 36% ≥60 years compared with 28%
in the general population [39], women were overrepre-
sented, and the proportion with higher education was
56% compared with 33% in the general population. The
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estimated population average antibiotic knowledge score
weighted by age, gender and education is therefore
understandably lower. The question is whether it is still
an overestimate. According to Statistics Norway, 12% of
the Norwegian population in 2016 had a health profes-
sional education [39]. The proportion was 27% in our
study sample, and having a health professional back-
ground was the single factor with strongest influence on
knowledge scores in our analysis.
There are no official statistics that demographically de-
scribe Norwegian pharmacy customers, i.e. our source
population. Compared with the population who redeemed
at least one prescription (The Norwegian Prescription
Database, NorPD) in 2016, our study sample includes
more women (68% versus 55% in NorPD), but the propor-
tion ≥ 60 years is comparable (36% versus 37% in NorPD).
However, the pharmacy customers in our study also in-
clude people merely buying over-the-counter medication
and various products marketed for health and well-being.
This may account for our higher proportion of younger
people, and particularly women.
Our study sample is relatively large, but with a moder-
ate response rate. The motivation to participate is prob-
ably higher among people with an interest in, or
experience with, antibiotics, which may contribute to an
overestimation of knowledge level. The proportion
reporting antibiotic use during the previous 12months
is fairly high (30%) compared to the one-year prevalence
from NorPD for 2016 (23%) [5], and comparable to the
Eurobarometer (34%) [11]. However, our data do not
consistently support that use of antibiotics during the
previous 12months is associated with antibiotic know-
ledge. The response rate was particularly low in Bergen
(19%) compared with Tromsø (55%) and Skien (63%).
However, we found no significant association between
study site and antibiotic knowledge score (data not
shown), suggesting that non-response bias is not a ser-
ious threat to our estimates and interpretations.
The knowledge and attitude statements in our ques-
tionnaire were not validated, but were mainly based on
questionnaires used in previous studies [11, 26], and a
face validity study was conducted to ensure comprehen-
sibility. The interpretation of the results from the follow-
ing three knowledge statements would have benefited
from a more precise statement formulation: whether the
antibiotics with food statement is true or false, whether
penicillin is another word for antibiotics and whether
humans can become resistant to antibiotics.
Lack of scientific studies measuring the public’s know-
ledge about antibiotics and antibiotic resistance is worry-
ing given the global call to fight antibiotic resistance.
This study contributes to fill this gap. Moreover, it adds
to standard surveys, like the Eurobarometer, by includ-
ing measures of beliefs about medicines, attitudes
toward antibiotics as well as background characteristics,
thereby addressing risk factors for low level of know-
ledge. The study reveals knowledge gaps that should be
filled and groups that should be targeted for efforts to
increase the antibiotic knowledge. However, a large-scale
nation-wide study would be desirable.
Conclusion
We have identified a high level of knowledge of antibi-
otics, particularly antibiotic resistance, among Norwegian
pharmacy customers. This suggests that Norwegians are
aware that antibiotic resistance poses a health threat, and
that unnecessary use of antibiotics is driving this threat.
Nevertheless, there seems to be a knowledge gap when it
comes to understanding the rationale behind the resist-
ance problem. We suggest that action is taken to increase
public knowledge of antibiotics, particularly among people
without a health professional background, in less aca-
demic (vocational) and/or male dominated occupations.
We also suggest that fathers, as well as mothers, are tar-
geted in campaigns directed towards families with young
children. Additionally, the upcoming revision of the na-
tional curriculum for primary and secondary school
should include learning objectives regarding antibiotics
and antibiotic resistance.
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